vls3d.com
Vls3d - Open drug discovery
http://www.vls3d.com/links/related-tools/open-drug-discovery
Doctoral school for therapeutic Innovation. Computational Biology and Chemistry. Protein, DNA, RNA, Glycan modeling. Protein-protein docking, template-based docking. Hotspots, Interace residues, PPI modulators. PPI databases, network. Binding pockets and ligand-pocket datasets. Peptides, antibodies, epitopes. Visualization - commercial tools. Chemistry toolkits and utilities. Manage collections - chemical space. ADMET- physchem predictions - related tools. Off-targets, drug repurposing. Grants4Targets, G...
biospring.blogspot.com
BioSpring Blog: Open Innovation (in Biotech/Pharma)
http://biospring.blogspot.com/2012/11/open-innovation-in-biotechpharma.html
Tuesday, 27 November 2012. Open Innovation (in Biotech/Pharma). BIA breakfast meeting 28/11/12, BioCity, Nottingham. One of a series of BIA Breakfast events around the UK; Chaired by BIA CEO Steve Bates, with panel members Clare O’Neil, Original Ventures and Nick Pope, BioSpring Ltd. Rting material for Nick’s contribution:. Can mean one, or both, of:. 1 Collaborative v’s competitive, trusting, operating with a “Win Win” ethos, or. 2 Open to outside ideas (Big Pharma). Eg drug molecule screening in silico.
lifeischemistry.com
Uncategorized | Life is Chemistry
https://lifeischemistry.com/category/uncategorized
Skip to main content. Skip to primary sidebar. Skip to secondary sidebar. Because everything around us is chemistry. Free Online 2015 Drug Design and Delivery Symposium by ACS. The American Chemical Society. Oranizes a free four-module symposiumon Drug Design and Delivery. Module 1: Improving Drug Design Efficiency and Efficacy. Module 2: Activity/Potency Screening for Drug Lead and Candidate Optimization. Module 3: Enabling Drug Delivery. Register HERE for free. FDA Approves 27 New Drugs in 2013. Is a f...
icp.medicine.iu.edu
Industry RFA: Grants & Funding: Industry Collaboration Portal: Indiana University
https://icp.medicine.iu.edu/grants-funding/industry-rfa.html
IU School of Medicine. CTSI and Other IU RFA. GSK Discovery Fast Track Challenge. The Discovery Fast Track Challenge. Is a challenge that recognizes and rewards innovative concepts, discoveries, and research by investigators at U.S. and Canadian research institutions, colleges, and universities. Winning investigators will collaborate with a team of GSK scientists to put their innovative research concept on an accelerated drug discovery path. Johnson and Johnson Innovation Centers. Partner with academic ...
biospring.blogspot.com
BioSpring Blog: November 2012
http://biospring.blogspot.com/2012_11_01_archive.html
Tuesday, 27 November 2012. Open Innovation (in Biotech/Pharma). BIA breakfast meeting 28/11/12, BioCity, Nottingham. One of a series of BIA Breakfast events around the UK; Chaired by BIA CEO Steve Bates, with panel members Clare O’Neil, Original Ventures and Nick Pope, BioSpring Ltd. Rting material for Nick’s contribution:. Can mean one, or both, of:. 1 Collaborative v’s competitive, trusting, operating with a “Win Win” ethos, or. 2 Open to outside ideas (Big Pharma). Eg drug molecule screening in silico.
balticip.wordpress.com
Connecting Compounds to Patients | Baltic IP
https://balticip.wordpress.com/2011/11/13/connecting-compounds-to-patients
Just another WordPress.com site. Connecting Compounds to Patients. The new platform consists of three components:. TD2, or target drug discovery, a new component that screens submitted molecules for their potential to interact with known disease targets. PD2, which continues to screen submitted molecules in complex cellular assays with the goal of identifying potential new medicines acting by novel mechanisms or pathways. How the Open Innovation Drug Discovery Platform Works. Visit the website here.
toolsofscience.se
Open Innovation | Tools of Science - The Gateway to Life Science Capacities
http://toolsofscience.se/content/open-innovation
Skip to main content. A non-exhaustive list of open innovation initiatives found within life science is presented below. The term open innovation is here interpreted broadly as there are different degrees to openness in the listed initiatives. Since the scope of the initiatives changes over time only a very short description is provided together with a link where up to date information can be found. Concerning open innovation initatives relevant for the life science industry is encouraged. As a mean to f...
cambridgemedchemconsulting.com
Drug Discovery Resources | Cambridge MedChem Consulting
http://www.cambridgemedchemconsulting.com/resources
These pages are intended to act as a resource for scientists undertaking drug discovery, they were initially based on a course I give but have been expanded to give much more detail and to cover subjects not covered in the course. The headings without links give an idea of what is in progress. If you have any suggestions or additions to the content I'd be delighted to hear from you. Drug Discovery Stage definitions. Building a Sample Collection. Building a Fragment Collection. Ester and Amide Bioisosteres.
